Caredx

Yahoo Finance • 2 months ago

CareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., October 11, 2024--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, hi... Full story

Yahoo Finance • 2 months ago

CareDx Announces Closure of DOJ Investigation with No Finding of Wrongdoing

DOJ Concludes Investigation and Declines to Prosecute BRISBANE, Calif., October 08, 2024--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development,... Full story

Yahoo Finance • 3 months ago

CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., September 14, 2024--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated,... Full story

Yahoo Finance • 5 months ago

CareDx to Report Second Quarter 2024 Financial Results

BRISBANE, Calif., July 16, 2024--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transpla... Full story

Yahoo Finance • 11 months ago

CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2023

BRISBANE, Calif., January 09, 2024--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for trans... Full story

Yahoo Finance • last year

CareDx Joins Forces with the National Foundation for Transplants to Improve Post-Transplant Medication Adherence

CareDx Expands Reach of its Transplant Pharmacy Services by Offering NFT Patients Help in Navigating the Complexity of Immunosuppression Medications and Adherence BRISBANE, Calif., December 19, 2023--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq:... Full story

Yahoo Finance • last year

CareDx to Report Third Quarter 2023 Financial Results

BRISBANE, Calif., November 02, 2023--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for tran... Full story

Yahoo Finance • last year

Market Today: Tech Stocks Under Pressure, House Ousts McCarthy, and FTC Accuses Amazon of Price ...

On 10-03-2023, the S&P 500, Dow Jones Industrial Average, and Nasdaq Composite all experienced significant declines, with the Nasdaq leading the downturn with a 1.9% drop. The 10-year Treasury yield rose by 2.26% to 4.795%, reflecting the... Full story

Yahoo Finance • last year

CareDx’s AlloSure Lung dd-cfDNA Testing Service Receives Medicare Coverage for Lung Transplant Rejection Monitoring

AlloSure Lung Represents First dd-cfDNA Approved by Medicare for Lung Transplant Patients BRISBANE, Calif., July 11, 2023--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and c... Full story

Yahoo Finance • last year

We're Hopeful That CareDx (NASDAQ:CDNA) Will Use Its Cash Wisely

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares since 1999, you would have made a fortune. No... Full story

Yahoo Finance • 2 years ago

CareDx Showcases Latest Advances Across AlloSeq Lab Products Portfolio at the 36th European Immunogenetics and Histocompatibility Conference

Posters and Symposium Highlight Utility of AlloSeq for HLA Typing, Organ Transplant Monitoring and Hematopoietic Stem Cell Monitoring BRISBANE, Calif., April 25, 2023--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), a leading precision medi... Full story

Yahoo Finance • 2 years ago

SHAREHOLDER ALERT: Morris Kandinov Investigating LFST, BRY, CDNA, and OPEN; Shareholders are Encouraged to Contact the Firm

SAN DIEGO, April 19, 2023 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating the actions of the officers and board of directors of LifeStance Health Group, Inc., Berry Corporation, CareDx, Inc., and Opendoor Technolog... Full story

Yahoo Finance • 2 years ago

CareDx, Inc's (NASDAQ:CDNA) Shares Lagging The Industry But So Is The Business

With a price-to-sales (or "P/S") ratio of 1.6x CareDx, Inc (NASDAQ:CDNA) may be sending very bullish signals at the moment, given that almost half of all the Biotechs companies in the United States have P/S ratios greater than 11.8x and ev... Full story

Yahoo Finance • 2 years ago

CareDx Reports Fourth Quarter and Full Year 2022 Results

BRISBANE, Calif., February 27, 2023--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for tran... Full story

Yahoo Finance • 2 years ago

Cathie Wood pours millions into these 2 stocks — this is what makes them attractive buys

January has now been and gone and turned out to be a nice gift for investors. Battered by 2022’s bear, the tech-heavy Nasdaq, in particular, put in an excellent showing, seeing out the month ~11% into the green, in what amounted to its bes... Full story

Yahoo Finance • 2 years ago

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Let's not try to jinx things by calling attention to this, but Cathie Wood's on a roll this year. The largest of the exchange-traded funds she runs at Ark Investment Management is up nearly 23% this month. Wood added to her existing stakes... Full story

Yahoo Finance • 2 years ago

Voyager Therapeutics Appoints Grace E. Colón, Ph.D., to its Board of Directors

CAMBRIDGE, Mass., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced the appointment of Grace E. Coló... Full story

Yahoo Finance • 2 years ago

Independent Prospective Study Defines Reference Range for CareDx’s AlloSure for Long-Term Lung Transplant Surveillance

First Study to Establish AlloSure Lung dd-cfDNA Baseline Beyond Two Years Post-Transplant by Evaluating Clinically Stable Patients BRISBANE, Calif., December 01, 2022--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™... Full story

Yahoo Finance • 2 years ago

CareDx Presents Latest Data on AlloSeq NGS Solutions and Transplant Innovation at the American Society for Histocompatibility and Immunogenetics Annual Meeting

CareDx Highlights Latest Innovations in HLA Typing and Hematopoietic Stem Cell Transplant Chimerism Monitoring BRISBANE, Calif., October 25, 2022--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the disco... Full story

Yahoo Finance • 2 years ago

Cathie Wood Goes Bargain-Shopping: 3 Stocks She Just Bought

Growth stocks associated with innovative healthcare businesses aren't getting the positive attention they deserve. At least that's what Cathie Wood's recent purchases suggest. Recently, the CEO of ARK Investment Management added heavily to... Full story